Search for: "PFIZER V TEVA PHARMACEUTICALS" Results 21 - 40 of 183
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Dec 2018, 10:34 am by Sanford Hausler
  It sought to obtain settlement agreement, licensing agreements and any other related agreements between King Pharmaceuticals , Meridian Technologies, Inc. and Pfizer, Inc., the respondents in the proceeding (collectively, the "Respondents") and Teva Pharmaceutical Industries, Ltd. [read post]
28 Mar 2014, 5:33 pm
Teva Pharmaceuticals USA, Inc., Nos. 2012-1576, -1601, -1602, -1603, -1604, -1605, -1607 (Fed. [read post]
26 Nov 2012, 4:00 am by Martin Kratz
Trent Horne and Edward (Ted) Yoo In a unanimous decision, the Supreme Court of Canada has provided valuable guidance to patent agents and litigators as to how Canadian patents will be read and enforced (Teva Canada Limited v Pfizer Canada Inc, 2012 SCC 60). [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 11/23: Pfizer, Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company and Warner-Lambert Company, LLC v. [read post]
14 Jan 2013, 6:19 am by Mark Zamora
Although he took only generics, Weeks accused Wyeth, which sold Reglan and is now owned by Pfizer as well as two generic drugmakers – Teva Pharmaceuticals and Actavis – of failing to warn of the risk of long-term use.At issue was whether Weeks could press his lawsuit against Pfizer, a question that a federal court asked the Alabama Supreme Court to decide. [read post]
9 May 2013, 5:34 am
The lawsuit names Pfizer, as well as two different generic drug manufacturers - Actavis Elizabeth and Teva Pharmaceuticals - in the U.S. [read post]
17 May 2007, 9:09 am
Teva Pharmaceuticals USA Inc., No. 06-0282, 22 BNA Toxic Law Rptr. #20 (S.D. [read post]
18 Feb 2020, 4:00 am by Martin Kratz
Pfizer Canada ULC, 2020 FC 1, at para. 56. [15] See Seedlings Life Science Ventures, LLC v. [read post]
3 Mar 2015, 1:55 am
  Counsel for Pfizer drew analogy between this situation and “the situation where an injunction is sought pending appeal even though the patent has been held invalid at first instance, as to which see Novartis AG v Hospira UK Ltd [2013] EWCA Civ 583, [2014] 1 WLR 1264. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
27 Dec 2012, 3:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2012 WL 1866839, at *5 (W.D. [read post]
16 Sep 2007, 5:50 pm
The Federal Circuit reissued its July 11 opinion in Daiichi Sankyo v. [read post]